Status
Conditions
Treatments
About
The purpose of this translational bench-to-bedside study is to examine the neurobiological effects of an evidence-based technology-delivered mindfulness training (MT) program on vaping-related rsFC alterations in hippocampal networks and testing whether changes in rsFC ((Delta)rsFC) in these networks predict reduction in tobacco vaping behaviors in adolescents. The study also aims to test the accessibility and feasibility of using this mindfulness-based stress reduction (MBSR) platform as an implementation for widespread MT in adolescents....
Full description
Study Description:
This protocol will use fMRI and in-person and technology-delivered mindfulness-based stress reduction (MBSR) training to elucidate neurobehavioral correlates of regular nicotine vaping in adolescents compared to non-vaping adolescents, and changes in these correlates after MBSR training. Our central hypothesis is that nicotine vaping in adolescents will be associated with impaired hippocampal connectivity with large-scale brain networks (e.g., Executive Control network (ECN), Default Mode Network (DMN), Salience Network (SN)) involved in cognitive control and emotion regulation and decreased state transitions (measured via dynamic resting state functional connectivity (rsFC)); and that MBSR training will increase hippocampal connectivity to ECN and alter time in state and state transitions in frequent vaping adolescents, with these rsFC changes predicting changes in vaping behavior.
Objectives:
Primary Objectives:
Secondary Objectives:
Endpoints:
Primary Endpoints:
Secondary Endpoint:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Non-Vaping group:
Vaping group:
EXCLUSION CRITERIA:
An individual who meets any of the following criteria will be excluded from participation in this study based on self and or parent-report unless otherwise noted:
Vaping or Non-Vaping Group:
Primary purpose
Allocation
Interventional model
Masking
14 participants in 1 patient group
Loading...
Central trial contact
Betty Jo Salmeron, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal